Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 5,000 shares at $76.00 ($380K) on 2023-09-08, disclosed to the SEC on 2023-09-08.
Scheduled sale ($380k) by CVP, Critical Care under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |
| EW | SELL | 2023-06-13 | $429K | — | Filing → |